Category Archives: Preclinical GLP Compliance with whole slide imaging

Regulatory issues around the use of whole slide images and digital pathology in GLP preclinical toxicology studies

Shoveling Slides

Legal disclaimer: This post has nothing to do with digital pathology. It is just a personal battle between a man, new technology, a steep driveway, and a lot of snow. It has nothing to do with digital pathology. I live on a steep driveway in Flagstaff, Arizona. We get snow, about the same amount as Denver [...]

Vets versus MDs in adoption rates

This blog was first posted on LabSoftNews. There are approximately 1,200 board-certified veterinary pathologists in the U.S. working in a variety of settings including veterinary schools, clinics, pharmaceutical companies, governmental agencies, and contract research organizations (CROs). Approximately 500 veterinary pathologists work in the U.S. pharmaceutical industry with a consistent industry average of about one pathologist [...]

2E=2L=2S Pathology Adoption

Back in the 90s during graduate school I was excited about an idea in cardiovascular imaging and talked to a stent lab cardiologist who had successfully started a number of companies. I told him my idea, and I will never forget his response. “Steve, Wall Street treats these three mistakes exactly the same. Too early, [...]

VIPER — Virtual Imaging in Peer Reviews

While we at Flagship do not believe whole slide imaging is ready yet for primary read in toxicology studies, we are working to offer peer review and image analysis in formal GLP studies. We are undergoing GLP validation for image analysis, and have formed a group called VIPER, or Virtual Imaging in Peer Reviews, to [...]